The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells
Article in BMC Cancer (May 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Article in BMC Cancer (May 2024)
Article in Discover Oncology (March 2024)
Article in Discover Oncology (January 2024)